
GHK-CU 50mg — 10-Pack
10-Pack — Copper Tripeptide Complex
Direct-source pricing: Solira works through manufacturing partnerships to reduce reseller markup while maintaining independent third-party testing and lot-specific COA verification.
Buy 3 or more units (any mix) and save 5% off — no code needed, applied at checkout. Mix any compounds.
Product Specifications
Research Applications
- Investigated in preclinical models for copper ion transport and chaperone activity in cellular systems.
- Studied in in vitro systems for collagen and elastin gene expression in dermal fibroblast cultures.
- Used in laboratory research examining extracellular matrix component turnover.
- Evaluated in controlled preclinical settings for antioxidant enzyme pathway modulation.
Storage & Handling
Store sealed, dry, and protected from light.
Long-term storage: -20°C recommended.
Short-term storage: 2-8°C acceptable.
Reconstitution: Use sterile technique with bacteriostatic water.
Post-reconstitution: Stable up to 30 days at 2-8°C.
All handling instructions are intended for laboratory use only.
Certificate of Analysis
Every batch of product sold by Solira undergoes independent third-party analytical testing to verify identity and purity.
- HPLC purity analysis — confirms compound purity
- Mass spectrometry — identity confirmation via molecular weight verification
- Lot-specific documentation — each COA corresponds to the specific manufacturing lot
Tested lot R56-481 (50 mg) — reference for all GHK-Cu sizes

The full lab results for this lot are published in text on its Certificate of Analysis page. Each figure is also independently verifiable at the testing laboratory.
This product is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use. All products sold by Solira are for laboratory and research purposes only. Not for human consumption. Not for diagnostic or therapeutic use. Purchaser assumes all responsibility for the legal and proper use of this product.




